DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Tolaney SM, Kalinsky K, Kaklamani VG. et al.
A phase Ib/II study of eribulin (ERI) plus pembrolizumab (PEMBRO) in metastatic triple-negative breast cancer (mTNBC) (ENHANCE 1).
J Clin Oncol 2020;
38: 1015-1015
We do not assume any responsibility for the contents of the web pages of other providers.